Viewing Study NCT03336502


Ignite Creation Date: 2025-12-25 @ 3:45 AM
Ignite Modification Date: 2026-03-02 @ 4:23 PM
Study NCT ID: NCT03336502
Status: COMPLETED
Last Update Posted: 2019-12-19
First Post: 2017-11-06
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Pharmacokinetics and Safety of Intravenous Posaconazole (MK-5592) in Chinese Participants at High Risk for Invasive Fungal Infections (MK-5592-120)
Sponsor: Merck Sharp & Dohme LLC
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2017-12-20
Start Date Type: ACTUAL
Primary Completion Date: 2018-11-26
Primary Completion Date Type: ACTUAL
Completion Date: 2018-11-26
Completion Date Type: ACTUAL
First Submit Date: 2017-11-06
First Submit QC Date: None
Study First Post Date: 2017-11-08
Study First Post Date Type: ACTUAL
Results First Submit Date: 2019-10-25
Results First Submit QC Date: None
Results First Post Date: 2019-12-19
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2019-12-02
Last Update Post Date: 2019-12-19
Last Update Post Date Type: ACTUAL